Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Berger

Showing results (1011-1020 of 1,161) with videos related to

Pageof 117
Sort By:
Annals of Surgical Oncology|July 19, 2025
Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and Colloid Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: An International Multicenter Retrospective StudyJoseph R Habib, Camila Hidalgo Salinas, Natalie F Berger, et al.
The Oncologist|June 28, 2024
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapyDarren Cowzer, Joanne F Chou, Henry Walch, et al.
Heart (British Cardiac Society)|April 15, 2016
Surgical options after Fontan failureJoost P van Melle, Djoeke Wolff, Jürgen Hörer, et al.
Blood|June 4, 2017
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMMLAkihide Yoshimi, Maria E Balasis, Alexis Vedder, et al.
JAMA Oncology|November 15, 2019
Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer CareAlexander Penson, Niedzica Camacho, Youyun Zheng, et al.
Leukemia|January 7, 2012
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implicationsV Bikos, N Darzentas, A Hadzidimitriou, et al.
The Oncologist|October 2, 2019
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric CancerRyan H Moy, Gustavo Dos Santos Fernandes, Philip Jonsson, et al.
Cancer Discovery|June 18, 2014
Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapyHikmat Al-Ahmadie, Gopa Iyer, Marcel Hohl, et al.
Cancer Discovery|October 18, 2023
Quantifying the Expanding Landscape of Clinical Actionability for Patients with CancerSarah P Suehnholz, Moriah H Nissan, Hongxin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial CarcinomaFrançois Audenet, Sumit Isharwal, Eugene K Cha, et al.
Pageof 117

Showing results (1011-1020 of 1,161) with videos related to

Sort By:
Pageof 117
Annals of Surgical Oncology|July 19, 2025
Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and Colloid Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: An International Multicenter Retrospective StudyJoseph R Habib, Camila Hidalgo Salinas, Natalie F Berger, et al.
The Oncologist|June 28, 2024
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapyDarren Cowzer, Joanne F Chou, Henry Walch, et al.
Heart (British Cardiac Society)|April 15, 2016
Surgical options after Fontan failureJoost P van Melle, Djoeke Wolff, Jürgen Hörer, et al.
Blood|June 4, 2017
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMMLAkihide Yoshimi, Maria E Balasis, Alexis Vedder, et al.
JAMA Oncology|November 15, 2019
Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer CareAlexander Penson, Niedzica Camacho, Youyun Zheng, et al.
Leukemia|January 7, 2012
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implicationsV Bikos, N Darzentas, A Hadzidimitriou, et al.
The Oncologist|October 2, 2019
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric CancerRyan H Moy, Gustavo Dos Santos Fernandes, Philip Jonsson, et al.
Cancer Discovery|June 18, 2014
Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapyHikmat Al-Ahmadie, Gopa Iyer, Marcel Hohl, et al.
Cancer Discovery|October 18, 2023
Quantifying the Expanding Landscape of Clinical Actionability for Patients with CancerSarah P Suehnholz, Moriah H Nissan, Hongxin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial CarcinomaFrançois Audenet, Sumit Isharwal, Eugene K Cha, et al.
Pageof 117